VP (Research and International Relations) news
At the session held on September 19 with both AMURE bargaining units, the university explained its position on layoffs, end of contracts and recalls of research associates and assistants. This led to questions and several exchanges between the parties. A tentative agreement on the majority of these elements was presented by McGill. The parties reached an agreement in principle on the majority of the issues at hand, but were unable to reach an agreement on the notice of termination of employment.
Lancement de l'appel de propositions
McGill University and Intellectual Ventures have announced a partnership that provides an additional avenue for McGill faculty to commercialize their inventions and discoveries.
We’ve known for a while that the vestibular system in the inner ear is responsible for helping us keep our balance. And while researchers have already developed a basic understanding of how the brain constructs our perceptions of ourselves in motion, until now no one has understood the crucial step by which the neurons in the brain select the information needed to do so.
The bargaining session of July 11 between the University and AMURE led to signed agreements on grievance procedure (Art. 12), arbitration (Art. 13) and disciplinary measures (Art. 14).
Fourteen of the 156 new 2012 Vanier Scholars will be attending McGill University, coming from countries as diverse as Australia, Belgium, Peru and the United States, as well as from Canada.
Two projects led by McGill professors are among the 17 that will receive a total of $28 million over six years to help science and engineering graduates add job skills to their academic achievements, thanks to the.Natural Sciences and Engineering Research Council of Canada’s (NSERC) CREATE program. The two projects are the CREATE program in green chemistry led by Prof. Chao-Jun Li, and the CREATE
A new study published in the journal Arthritis Care & Research, led by Dr. Mary-Ann Fitzcharles, a rheumatologist at the McGill University Health Centre, reveals that 13 per cent of FM patients use cannabinoids for relief from symptoms such as widespread pain, fatigue, and insomnia.
McGill University scientists, led by Ajjamada Kushalappa of the Faculty of Agricultural and Environmental Sciences, have teamed up with researchers from the Universidad Nacional de Colombia to develop nutritious, high-yielding, and more disease-resistant potatoes for food-insecure indigenous communities in Colombia.
Mauro Dell’Ambrogio, Swiss Secretary of State for Education and Research, and Ulrich Lehner, Ambassador of Switzerland to Canada and the Bahamas, recently paid a high-profile visit to McGill University. One of their primary goals was to show support for and learn more about the innovative partnership that exists between the Brain@McGill and the Neuroscience Center Zurich.
Report by blue-ribbon panel, including McGill Principal Munroe-Blum, highlights links between world-class research universities and future prosperity
Cachexia, a syndrome characterized by rapid weight loss and muscle deterioration, is a major cause of death among patients suffering from diseases like cancer, AIDS and chronic infection. Now, a newly published study by McGill University researchers shows that a low dose of Pateamine A is effective at preventing cancer-induced muscle wasting, which may lead to cachexia-fighting drugs.